Pfeffingerstrasse 19
4153 Reinach BL
UID: CHE113359497
Baliopharm AG is registered in the Swiss commercial registry. This listing is informational and has not yet been evaluated against the SwissMastery SSI™ criteria.
Baliopharm AG is a biotechnology company specializing in the development of innovative therapeutic antibodies and antibody-derived proteins for the treatment of chronic liver diseases, autoimmune conditions, and cancer.
Aktiengesellschaft
Société anonyme
Reinach (BL)
Basel-Landschaft
Manufacturing
Pfeffingerstrasse 19
4153
Reinach BL
2007-01-08
CHE113359497
Company profiles are informational listings and do not imply endorsement, verification or partnership unless explicitly stated.
We use cookies to improve your experience. Essential cookies are always active. You may accept optional analytics cookies or continue with essential cookies only. Privacy Policy